![](/img/cover-not-exists.png)
Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
Zhang, Yingshi, Li, Dandan, Jiang, Qiyu, Cao, Shuang, Sun, Huiwei, Chai, Yantao, Li, Xiaojuan, Ren, Tianshu, Yang, Ruichuang, Feng, Fan, Li, Bo-an, Zhao, QingchunVolume:
9
Language:
english
Journal:
Cell Death & Disease
DOI:
10.1038/s41419-018-0804-6
Date:
July, 2018
File:
PDF, 4.00 MB
english, 2018